Erratum: Correction of Figures. The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis

Article information

Asian Spine J. 2015;9(6):999-1000
Publication date (electronic) : 2015 December 08
doi : https://doi.org/10.4184/asj.2015.9.6.999
1Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
2Department of Orthopedic Surgery, National Hospital Organization Chiba Medical Center, Chiba, Japan.
3Department of Orthopedic Surgery, Teikyo University Chiba Medical Center, Chiba, Japan.

Asian Spine J 2015;9(3):338-343

http://dx.doi.org/10.4184/asj.2015.9.3.338

Corrections for Fig. 2, Fig. 3, and Fig. 4 in page 340 are needed.

There were some mistakes in the numerical values of the graphs. We apologize for any inconvenience that this may have caused.

• Before correction

Fig. 2. P1NP levels before and 1 month after administrating the anti-RANKL antibody. P1NP, N-terminal propeptide of type 1 collagen; RANKL, receptor activator of nuclear factor-kappa B ligand; NS, not significant.

• After correction

Fig. 2. P1NP levels before and 1 month after administrating the anti-RANKL antibody. P1NP, N-terminal propeptide of type 1 collagen; RANKL, receptor activator of nuclear factor-kappa B ligand; NS, not significant.

• Before correction

Fig. 3. The averages YAM level for the anti-RANKL antibody before and 6 months after treatment. YAM, young adult mean; RANKL, receptor activator of nuclear factor-kappa B ligand.

• After correction

Fig. 3. The averages YAM level for the anti-RANKL antibody before and 6 months after treatment. YAM, young adult mean; RANKL, receptor activator of nuclear factor-kappa B ligand.

• Before correction

Fig. 4. The time course changes by using the back pain VAS before treatment and 1, 2, 3, and 6 months after treatment. VAS, visual analogue scale; NS, not significant.

• After correction

Fig. 4. The time course changes by using the back pain VAS before treatment and 1, 2, 3, and 6 months after treatment. VAS, visual analogue scale; NS, not significant.

Article information Continued